世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000031756

アルツハイマー病治療の世界市場レポート(2022年)

The Business Research Company

Alzheimer’s Disease Treatment Global Market Report 2022

発刊日 2022/03/02

言語英語

体裁PDF/400ページ

ライセンス/価格400ページ

0000031756

Single
Site
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※受注後、レポートは最新版へ更新されますので、納品までに3〜5営業日かかります。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、戦略担当者、マーケティング担当者、経営幹部に、世界のアルツハイマー病治療市場を評価するために必要な重要な情報を提供します。

また、力強い成長を遂げているアルツハイマー病治療市場に焦点を当てています。本レポートは、世界的なパンデミックという課題に対する市場の対応など、今後10年以上にわたって私たちの生活を形作り変化させるアルツハイマー病治療市場へのガイドを提供します。

調査範囲

  • 調査市場
    ➣ 薬剤クラス別
      ◇ コリン作動性
      ◇ メマンチン
      ◇ 併用薬
      ◇ AChE阻害薬
      ◇ 免疫グロブリン
    ➣ 薬剤タイプ別
      ◇ コリンエステラーゼ阻害薬
      ◇ NMDA受容体拮抗薬
    ➣ 治療薬別
      ◇ コリンエステラーゼ阻害薬
      ◇ NMDA受容体拮抗薬
      ◇ その他の治療薬
  • 調査企業
    ➣ Allergan
    ➣ エーザイ(Eisai Co. Ltd.)
    ➣ Novartis AG
    ➣ Pfizer Inc.
    ➣ Merz Pharma
  • 調査国
    ➣ オーストラリア、ブラジル、中国、フランス、ドイツ、インド、インドネシア、日本、ロシア、韓国、イギリス、アメリカ
  • 調査地域
    ➣ アジア太平洋地域
    ➣ 西ヨーロッパ
    ➣ 東ヨーロッパ
    ➣ 北アメリカ
    ➣ 南アメリカ
    ➣ 中東
    ➣ アフリカ
  • 調査期間
    ➣ 5年間の実績データおよび10年間の予測
  • データ
    ➣ 市場規模と成長率の関連市場に対する比率
    ➣ GDP比率
    ➣ 一人当たりの支出
  • データセグメント
    ➣ 国別・地域別の実績および予測データ
    ➣ 競合企業の市場シェア
    ➣ 市場セグメント
  • 情報源および参照
    ➣ 本レポートのデータおよび分析は、注釈で出典を明らかにしています。

レポート詳細

目次

Table of Contents

1. Executive Summary

2. Alzheimer's Disease Treatment Market Characteristics

3. Alzheimer's Disease Treatment Market Trends And Strategies

4. Impact Of COVID-19 On Alzheimer's Disease Treatment

5. Alzheimer's Disease Treatment Market Size And Growth
5.1. Global Alzheimer's Disease Treatment Historic Market, 2016-2021, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Alzheimer's Disease Treatment Forecast Market, 2021-2026F, 2031F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market

6. Alzheimer's Disease Treatment Market Segmentation
6.1. Global Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Cholinergic
Memantine
Combined Drug
AChE inhibitors
Immunoglobulins
6.2. Global Alzheimer's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Cholinesterase Inhibitors
NMDA Receptor Antagonists
6.3. Global Alzheimer's Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Cholinesterase Inhibitors
NMDA Receptor Antagonists
Other Therapeutics

7. Alzheimer's Disease Treatment Market Regional And Country Analysis
7.1. Global Alzheimer's Disease Treatment Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7.2. Global Alzheimer's Disease Treatment Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

8. Asia-Pacific Alzheimer's Disease Treatment Market
8.1. Asia-Pacific Alzheimer's Disease Treatment Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

9. China Alzheimer's Disease Treatment Market
9.1. China Alzheimer's Disease Treatment Market Overview
9.2. China Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

10. India Alzheimer's Disease Treatment Market
10.1. India Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

11. Japan Alzheimer's Disease Treatment Market
11.1. Japan Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

12. Australia Alzheimer's Disease Treatment Market
12.1. Australia Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

13. Indonesia Alzheimer's Disease Treatment Market
13.1. Indonesia Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

14. South Korea Alzheimer's Disease Treatment Market
14.1. South Korea Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

15. Western Europe Alzheimer's Disease Treatment Market
15.1. Western Europe Alzheimer's Disease Treatment Market Overview
15.2. Western Europe Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

16. UK Alzheimer's Disease Treatment Market
16.1. UK Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

17. Germany Alzheimer's Disease Treatment Market
17.1. Germany Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

18. France Alzheimer's Disease Treatment Market
18.3. France Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

19. Eastern Europe Alzheimer's Disease Treatment Market
19.1. Eastern Europe Alzheimer's Disease Treatment Market Overview
19.2. Eastern Europe Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

20. Russia Alzheimer's Disease Treatment Market
20.1. Russia Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

21. North America Alzheimer's Disease Treatment Market
21.1. North America Alzheimer's Disease Treatment Market Overview
21.2. North America Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

22. USA Alzheimer's Disease Treatment Market
22.1. USA Alzheimer's Disease Treatment Market Overview
22.2. USA Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

23. South America Alzheimer's Disease Treatment Market
23.1. South America Alzheimer's Disease Treatment Market Overview
23.2. South America Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

24. Brazil Alzheimer's Disease Treatment Market
24.1. Brazil Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

25. Middle East Alzheimer's Disease Treatment Market
25.1. Middle East Alzheimer's Disease Treatment Market Overview
25.2. Middle East Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

26. Africa Alzheimer's Disease Treatment Market
26.1. Africa Alzheimer's Disease Treatment Market Overview
26.2. Africa Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

27. Alzheimer's Disease Treatment Market Competitive Landscape And Company Profiles
27.1. Alzheimer's Disease Treatment Market Competitive Landscape
27.2. Alzheimer's Disease Treatment Market Company Profiles
27.2.1. Allergan
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Eisai Co. Ltd.
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Novartis AG
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Pfizer Inc.
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Merz Pharma
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance

28. Alzheimer's Disease Treatment Pipeline Analysis

29. Key Mergers And Acquisitions In The Alzheimer's Disease Treatment Market

30. Alzheimer's Disease Treatment Market Future Outlook and Potential Analysis

31. Appendix
31.1. Abbreviations
31.2. Currencies
31.3. Research Inquiries
31.4. The Business Research Company
31.5. Copyright And Disclaimer

List of Tables
Table 1: Global Historic Market Growth, 2016-2021, $ Billion
Table 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
Table 3: Global Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 4: Global Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 5: Global Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 6: Global Alzheimer’s Disease Treatment Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 7: Global Alzheimer’s Disease Treatment Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 8: Asia-Pacific, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 9: China, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 10: India, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 11: Japan, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 12: Australia, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 13: Indonesia, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 14: South Korea, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 15: Western Europe, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 16: UK, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 17: Germany, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 18: France, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 19: Eastern Europe, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 20: Russia, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 21: North America, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 22: USA, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 23: South America, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 24: Brazil, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 25: Middle East, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 26: Africa, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 27: Allergan Financial Performance
Table 28: Eisai Co. Ltd. Financial Performance
Table 29: Novartis AG Financial Performance
Table 30: Pfizer Inc. Financial Performance
Table 31: Merz Pharma Financial Performance

List of Figures
Figure 1: Global Historic Market Growth, 2016-2021, $ Billion
Figure 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
Figure 3: Global Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 4: Global Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 5: Global Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 6: Global Alzheimer’s Disease Treatment Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 7: Global Alzheimer’s Disease Treatment Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 8: Asia-Pacific, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 9: China, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 10: India, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 11: Japan, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 12: Australia, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 13: Indonesia, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 14: South Korea, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 15: Western Europe, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 16: UK, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 17: Germany, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 18: France, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 19: Eastern Europe, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 20: Russia, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 21: North America, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 22: USA, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 23: South America, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 24: Brazil, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 25: Middle East, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 26: Africa, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 27: Allergan Financial Performance
Figure 28: Eisai Co. Ltd. Financial Performance
Figure 29: Novartis AG Financial Performance
Figure 30: Pfizer Inc. Financial Performance
Figure 31: Merz Pharma Financial Performance

この商品のレポートナンバー

0000031756

TOP